Bob Dagher
Directeur Technique/Scientifique/R&D chez BRAINSTORM CELL THERAPEUTICS INC.
Fortune : 134 596 $ au 30/04/2024
Provenance du réseau au premier degré de Bob Dagher
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
| Public Company | Pharmaceuticals: Other | 7 | |
| Subsidiary | Pharmaceuticals: Major | 7 | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bob Dagher via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| LABCORP HOLDINGS INC. | Services to the Health Industry | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sparta Pharmaceuticals, Inc.
 Sparta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Sparta Pharmaceuticals, Inc. acquires the rights to, and develops for commercialization, technologies and drugs for the treatment of diseases. The company is based in Horsham, PA. Sparta Pharmaceuticals was acquired by SuperGen, Inc. on August 13, 1999 for $12.28 million. The company was founded by Peter N. Christos. | Pharmaceuticals: Major | Corporate Officer/Principal | |
U.S. Bioscience, Inc.
 U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Biotechnology | Corporate Officer/Principal | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
| ELITE PHARMACEUTICALS, INC. | Pharmaceuticals: Generic | Director of Finance/CFO | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Miscellaneous Commercial Services | Treasurer | |
| CURIS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALZHEON, INC. | Biotechnology | Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Chief Operating Officer | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Global Energy, Inc.
 Global Energy, Inc. Chemicals: SpecialtyProcess Industries Global Energy, Inc. engages in provision of an environment and alternative energy resources. It intends to acquire build and operate facilities that will use a proprietary technology to produce alternative fuels. The company was founded on February 16, 1999 and is headquartered in Ramat Gan, Israel. | Chemicals: Specialty | Investor Relations Contact | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| Long Island University | College/University | Undergraduate Degree | |
| Mount Holyoke College | College/University | Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Chairman Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Milan | College/University | Doctorate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Director/Board Member | |
Fremont Health Corp.
 Fremont Health Corp. Hospital/Nursing ManagementHealth Services Fremont Health Corp. provides healthcare services. It specializes in the areas of cancer care, diabetes care, business health and maternity care. The company was founded in 1940 and is headquartered in Fremont, NE. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Chairman | |
Positive Healthcare Plc
 Positive Healthcare Plc Miscellaneous Commercial ServicesCommercial Services Positive Healthcare Plc offers healthcare staffing and recruitment services. It offers healthcare staffing and recruitment group providing doctors, nurses and allied Healthcare professionals to the NHS and private hospitals. The company is headquartered in Upshire, the United Kingdom. | Miscellaneous Commercial Services | Director of Finance/CFO | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ERASCA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
Creative Balloons GmbH
 Creative Balloons GmbH Medical SpecialtiesHealth Technology Creative Balloons GmbH is a leading German company in catheter technology that supplies intensive care units throughout Europe. The company is based in Waghaeusel, Germany and has 40 employees. The company has developed an innovative kathetersystem called hygh-tec that covers all requirements for modern stool management and opens up additional preventive medical and therapeutic possibilities. The system is designed to provide maximum patient safety and user orientation. The company was founded by Fred Göbel and he has been the CEO since incorporation. | Medical Specialties | Chairman | |
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
Bairex
 Bairex Internet Software/ServicesTechnology Services Bairex Medical is a company based in San Francisco, CA. | Internet Software/Services | Chief Executive Officer | |
| Morrison Advisory Consulting | Founder | ||
Protypia, Inc.
 Protypia, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Inotiv, Inc., Protypia, Inc. provides targeted tissue-based protein and peptide mass spectrometry solutions. The company is based in Nashville, TN. The company was founded in 2017 by Daniel C. Liebler. Daniel C. Liebler has been the CEO since 2017. Protypia was acquired by Inotiv, Inc. on July 07, 2022 for $11 million. | Miscellaneous Commercial Services | Director/Board Member | |
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Medical Distributors | Founder |
Statistiques
Internationale
| Etats-Unis | 41 |
| Israël | 4 |
| Irlande | 2 |
| Belgique | 2 |
| Italie | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 105 |
| Corporate Officer/Principal | 78 |
| Chief Executive Officer | 38 |
| Independent Dir/Board Member | 37 |
| Chairman | 34 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jacob Frenkel | 29 |
| Dave Grayzel | 23 |
| Robert Dickey | 23 |
| Jodie Morrison | 20 |
| James Bristol | 17 |
| Michael Webb | 17 |
| Bradley Thompson | 17 |
| John McBride | 17 |
| Irit Arbel | 15 |
| Menghisteab Bairu | 15 |
| David Ian Johnson | 15 |
| June Almenoff | 14 |
| Nir Naor | 11 |
| Jonathan Zung | 9 |
| Mark Gelder | 9 |
- Bourse
- Insiders
- Bob Dagher
- Connexions Sociétés
